Abstracts

IMMUNOLOGIC PREDICTORS OF NEURODEVELOPMENT IN HIV-EXPOSED AND -UNEXPOSED CHILDREN

Children who are HIV-exposed, uninfected (HEU) have worse neurodevelopmental (ND) outcomes compared to children who are HIV-unexposed (HU), but assessing ND in resource-poor settings is challenging. We measured cognitive, language and motor development in HEU and HU paired with pro- and anti-inflammatory plasma biomarkers in each child to identify potential biomarkers of poor ND outcomes.…

GROWTH FALTERING AND DEVELOPMENTAL DELAYS IN HIV-EXPOSED UNINFECTED INFANTS IN UGANDA

HIV exposed but uninfected infants (HEU) are at increased risk of impaired early linear growth and cognitive development. We examined associations between pre and postnatal growth and subsequent neurodevelopment in Ugandan HEUs, hypothesizing that early insults may explain alterations in both somatic growth and brain development. We prospectively followed a cohort of HEUs from birth…

MATERNAL VL TESTING IN BREASTFEEDING FOR TARGETED INFANT HIV TESTING: A SIMULATION

Challenges encountered by women during the postpartum period contribute to poor ART adherence leading to elevated maternal viral load (VL). In high-burden settings where at least 12m breastfeeding is recommended, this raises concerns about ongoing MTCT; enhanced VL monitoring during breastfeeding is widely discussed but there is little understanding of how detection of maternal viraemia…

CARDIOMETABOLIC HEALTH IN HIV+ AND HIV- PREGNANT SOUTH AFRICAN WOMEN

HIV and antiretroviral therapy (ART) frequently influences cardiometabolic health, including obesity, glucose metabolism, lipids, and blood pressure (BP), but there are few data on the cardiometabolic impact of HIV and ART in pregnancy. We consecutively enrolled HIV+ and HIV- women in routine antenatal care at 24-28 weeks’ gestation in Cape Town. At enrollment, women underwent…